SHR-1316 Combined With Chemotherapy and Chest Radiotherapy in ES-SCLC
Clinical trial NCT04562337 · UNKNOWN
Trial details
- NCT number
- NCT04562337
- Sponsor
- Shandong Cancer Hospital and Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-01
- Primary completion
- 2024-10-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.